A detailed history of Squarepoint Ops LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 19,002 shares of RZLT stock, worth $89,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,002
Previous 22,982 17.32%
Holding current value
$89,309
Previous $111,000 18.92%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$4.08 - $5.96 $16,238 - $23,720
-3,980 Reduced 17.32%
19,002 $90,000
Q3 2024

Nov 14, 2024

BUY
$4.13 - $5.31 $94,915 - $122,034
22,982 New
22,982 $111,000

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $182M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.